Back to Search
GERALD BAHR, MD
MD
Hospitalist Physician
NPI: 1639264153IndividualAccepts Medicare
Specialties, Licenses & Credentials
Internal Medicine Physician
Internal Medicine
Code: 207R00000X
ME125316(FL)
Hospitalist PhysicianPrimary
Hospitalist
Code: 208M00000X
ME125316(FL)
Education
NEW YORK MEDICAL COLLEGE
Class of 1972
Research & Publications (20)
A novel cellular RNA helicase, RH116, differentially regulates cell growth, programmed cell death and human immunodeficiency virus type 1 replication.
PMID 14645903·J Gen Virol·2003
4-observational
Clinical and immunological effects of a 6 week immunotherapy cycle with murabutide in HIV-1 patients with unsuccessful long-term antiretroviral treatment.
PMID 12716777·J Antimicrob Chemother·2003
3-trial
Discordant effects of interleukin-2 on viral and immune parameters in human immunodeficiency virus-1-infected monocyte-derived mature dendritic cells.
PMID 12699419·Clin Exp Immunol·2003
8-other
Non-specific immunotherapy of HIV-1 infection: potential use of the synthetic immunodulator murabutide.
PMID 12493780·J Antimicrob Chemother·2003
6-review
Selective regulation of human immunodeficiency virus-infected CD4(+) lymphocytes by a synthetic immunomodulator leads to potent virus suppression in vitro and in hu-PBL-SCID mice.
PMID 11435574·J Virol·2001
7-preclinical
The common mycobacterial antigens and their importance in the treatment of disease.
PMID 19355964·Curr Pharm Des·2009
6-review
Effect of muramyl peptides on mitochondrial respiration.
PMID 19076831·Clin Exp Immunol·2009
7-preclinical
Up-regulation of NOD1 and NOD2 through TLR4 and TNF-alpha in LPS-treated murine macrophages.
PMID 16757890·J Vet Med Sci·2006
7-preclinical
Differentially expressed genes in HIV-1-infected macrophages following treatment with the virus-suppressive immunomodulator murabutide.
PMID 14687943·Virus Res·2004
8-other
A phase I study of a six-week cycle of immunotherapy with Murabutide in HIV-1 patients naive to antiretrovirals.
PMID 12824957·Med Sci Monit·2003
3-trial
Clinical tolerance and immunologic effects after single or repeated administrations of the synthetic immunomodulator murabutide in HIV-1-infected patients.
PMID 12131566·J Acquir Immune Defic Syndr·2002
3-trial
The transcriptional response of human macrophages to murabutide reflects a spectrum of biological effects for the synthetic immunomodulator.
PMID 12067302·Clin Exp Immunol·2002
8-other
Variations in serum IL-7 and 90K/Mac-2 binding protein (Mac-2 BP) levels analysed in cohorts of HIV-1 patients and correlated with clinical changes following antiretroviral therapy.
PMID 11703373·Clin Exp Immunol·2001
8-other
Clinical tolerance and profile of cytokine induction in healthy volunteers following the simultaneous administration of ifn-alpha and the synthetic immunomodulator murabutide.
PMID 11576459·J Interferon Cytokine Res·2001
3-trial
SS-56, a novel cellular target of autoantibody responses in Sjögren syndrome and systemic lupus erythematosus.
PMID 11560955·J Clin Invest·2001
8-other
Enhanced maturation and functional capacity of monocyte-derived immature dendritic cells by the synthetic immunomodulator Murabutide.
PMID 11529939·Immunology·2001
8-other
Macrophage stimulation with Murabutide, an HIV-suppressive muramyl peptide derivative, selectively activates extracellular signal-regulated kinases 1 and 2, C/EBPbeta and STAT1: role of CD14 and Toll-like receptors 2 and 4.
PMID 11449348·Eur J Immunol·2001
7-preclinical
Modulation of cellular and humoral immune responses to a multiepitopic HIV-1 DNA vaccine by interleukin-18 DNA immunization/viral protein boost.
PMID 11282190·Vaccine·2001
7-preclinical
Cytokine analysis at the single cell level and lymphoproliferative responses to mycobacterial antigens in HIV-1 patients with successful virologic response to potent antiretrovirals.
PMID 11202236·J Clin Immunol·2000
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 515 WEKIVA COMMONS CIR
APOPKA, FL 32712 - Phone
- (407) 464-9516
Quick Facts
- NPI
- 1639264153
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 54
- Publications
- 20
Are you this provider?
Claim Your Profile